Intra-Cellular Therapies Inc (NASDAQ:ITCI)

25.89
Delayed Data
As of May 27
 +1.68 / +6.94%
Today’s Change
12.67
Today|||52-Week Range
30.72
+46.69%
Year-to-Date
No recent news for Intra-Cellular Therapies Inc.

Today’s Trading

Previous close24.21
Today’s open24.23
Day’s range-- - --
Volume211,037
Average volume (3 months)263,839
Market cap$846.6M
Dividend yield--
Data as of 05/27/2015

Growth & Valuation

Earnings growth (last year)+31.41%
Earnings growth (this year)-177.57%
Earnings growth (next 5 years)--
Revenue growth (last year)-78.91%
P/E ratioNM
Price/Sales875.93
Price/Book5.92

Competitors

 Today’s
change
Today’s
% change
ZFGNZafgen Inc+0.28+0.89%
TGTXTG Therapeutics Inc+0.07+0.44%
COCPCocrystal Pharma Inc+0.00+0.01%
OMEROmeros Corp-0.51-2.45%
Data as of 3:58pm ET, 05/27/2015

Financials

Next reporting dateAugust 11, 2015
EPS forecast (this quarter)-$0.70
Annual revenue (last year)$577.3K
Annual profit (last year)-$30.7M
Net profit margin-5,316.37%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Sharon Mates
CFO, Treasurer &
Vice President-Finance
Lawrence J. Hineline
Corporate headquarters
New York, New York

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers